Additionally, Yosikawa et al. analysed the PD-L1 immunohistochemical profiles of triple-negative breast cancers using the 73 − 10, SP142 and E1L3N clones and reported that the 73 − 10 test showed a higher positivity rate in immune and tumour cells [20]. This evidence concerns the gene CD274 and triple-negative breast carcinoma.